About EYESCREEN, INC.
Eyescreen, Inc. is a company specializing in drug and gene therapy testing using functionally viable human retina tissue. They offer innovative platforms for evaluating neuroprotective, antioxidative, and anti-inflammatory effects of drugs, as well as delivery methods for gene therapies in the human eye.
Testing multiple small molecule drugs simultaneously for neuroprotective, antioxidative, and anti-inflammatory effects in human retina tissueEvaluating efficient delivery and transfection of target tissues-cells in the human eyeConsulting, designing, and building research tools for ex vivo and ex-situ functional assessment of the retinaTesting the potential of drug molecules in 'living' human retina tissue in a preclinical settingDeveloping methods to test delivery of gene therapies in ex-situ human eyes via subretinal and intravitreal injections
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to EYESCREEN, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.